These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8914042)

  • 41. Natriuretic peptides: a new lipolytic pathway in human adipocytes.
    Sengenès C; Berlan M; De Glisezinski I; Lafontan M; Galitzky J
    FASEB J; 2000 Jul; 14(10):1345-51. PubMed ID: 10877827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic effects of ANG II antagonist in heart failure: improvement of cGMP generation from ANP.
    Maeda Y; Wada A; Tsutamoto T; Fukai D; Kinoshita M
    Am J Physiol; 1997 May; 272(5 Pt 2):H2139-45. PubMed ID: 9176279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
    Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
    Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of cGMP-phosphodiesterase restores the glomerular effects of atrial natriuretic factor in low sodium diet rats.
    Kalinowski L; Szczepanska-Konkel M; Pawelczyk T; Bizon D; Angielski S
    Ren Physiol Biochem; 1995; 18(5):254-66. PubMed ID: 8869083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Angiotensin II decreases atrial natriuretic peptide-induced cyclic GMP accumulation in rat glomerular mesangial cells].
    Maeda S
    Nihon Jinzo Gakkai Shi; 1990 Feb; 32(2):183-90. PubMed ID: 2161960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
    Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
    Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gentamicin decreases guanylyl cyclase activity in rat glomerulus.
    Bae EH; Oh YW; Park JW; Ma SK; Choi KC; Lee J; Kim SH; Kim SW
    Kidney Blood Press Res; 2007; 30(2):81-7. PubMed ID: 17312373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.
    Ding KH; Abdel-Latif AA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2629-38. PubMed ID: 9375582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atrial natriuretic peptide effects on cGMP and cAMP contents in microdissected glomeruli and segments of the rat and rabbit nephrons.
    Chabardès D; Montégut M; Mistaoui M; Butlen D; Morel F
    Pflugers Arch; 1987 Apr; 408(4):366-72. PubMed ID: 2438641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells.
    Kishi Y; Ashikaga T; Watanabe R; Numano F
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):351-7. PubMed ID: 7528289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of atrial natriuretic peptide and sodium nitroprusside on epidermal growth factor-stimulated wound repair in rabbit corneal epithelial cells.
    Zhang Y; Islam M; Akhtar RA
    Curr Eye Res; 2000 Sep; 21(3):748-56. PubMed ID: 11120563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.
    Moro C; Klimcakova E; Lafontan M; Berlan M; Galitzky J
    Br J Pharmacol; 2007 Dec; 152(7):1102-10. PubMed ID: 17906676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclic nucleotide phosphodiesterases in glomeruli of rat renal cortex.
    Torres VE; Hui YS; Shah SV; Northrup TE; Dousa TP
    Kidney Int; 1978 Nov; 14(5):444-51. PubMed ID: 220459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR; Schittl J; Fischmeister R
    Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.